Germany
Japan
United Kingdom
China
Antibodies
Download
GPR44 / CRTH2 Rabbit Polyclonal (N-Terminus) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | GPR44 / CRTH2 antibody was raised against synthetic 33 amino acid peptide from N-terminal extracellular domain of human GPR44 / CRTH2. Percent identity with other species by BLAST analysis: Human, Gorilla, Gibbon (100%); Monkey (91%); Dog, Pig (88%); Rabbit (85%); Bovine (82%). |
GRPR Rabbit Polyclonal (Extracellular Domain) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Dog, Gorilla, Horse, Human, Monkey, Pig, Rabbit |
| Conjugation | Unconjugated |
| Immunogen | GRPR antibody was raised against synthetic 18 amino acid peptide from 2nd extracellular domain of human GRPR. Percent identity with other species by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Marmoset, Elephant, Panda, Dog, Bat, Horse, Rabbit, Pig (100%); Bovine (94%); Mouse, Rat, Hamster (83%). |
B1R / BDKRB1 Rabbit Polyclonal (Cytoplasmic Domain) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | B1R / BDKRB1 antibody was raised against synthetic 16 amino acid peptide from 1st cytoplasmic domain of human BDKRB1. Percent identity with other species by BLAST analysis: Human (100%); Gorilla, Gibbon, Monkey (94%); Horse (81%). |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Rabbit Polyclonal Anti-CYSLTR1 Antibody (C-Terminus)
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | CYSLTR1 / CYSLT1 antibody was raised against synthetic 20 amino acid peptide from C-terminus of human CYSLTR1 / CYSLT1. Percent identity with other species by BLAST analysis: Human, Gorilla (100%); Monkey, Marmoset (95%); Gibbon, Mouse, Panda (90%); Rat, Bovine, Elephant, Rabbit, Pig (85%). |
Goat Polyclonal Anti-Cathepsin D Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 275 aa to the C-terminus of human Cathepsin D produced in E. coli. |
Dopamine D2 Receptor / DRD2 Rabbit Polyclonal (Cytoplasmic Domain) Antibody
| Applications | IHC |
| Reactivities | Chimpanzee, Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | DRD2 / Dopamine Receptor D2 antibody was raised against synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human DRD2. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%); Gibbon, Monkey, Rabbit (95%); Dog, Bovine, Panda, Horse, Pig (89%); Mouse, Rat, Ferret, Bat, Hamster, Elephant (84%). |
Rabbit polyclonal ENOA Antibody (N-term)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This ENOA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 33-60 amino acids from the N-terminal region of human ENOA. |
Goat Polyclonal Anti-Cathepsin D Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 275 aa to the C-terminus of human Cathepsin D produced in E. coli. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Rabbit Polyclonal Antibody against PYGM (C-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PYGM antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 698-727 amino acids from the C-terminal region of human PYGM. |
Dopamine Receptor D3 / DRD3 Rabbit Polyclonal (Cytoplasmic Domain) Antibody
| Applications | IHC |
| Reactivities | Chimpanzee, Gorilla, Human, Monkey |
| Conjugation | Unconjugated |
| Immunogen | DRD3 / Dopamine Receptor D3 antibody was raised against synthetic 16 amino acid peptide from 3rd cytoplasmic domain of human DRD3 / Dopamine Receptor D3. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Marmoset (100%); Gibbon, Mouse, Dog, Bovine, Bat, Hamster, Elephant, Panda, Horse, Rabbit (94%); Rat, Pig, Opossum (88%). |
ADAMTS1 Rabbit Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Horse, Human, Monkey, Orang-Utan, Pig, Rabbit |
| Conjugation | Unconjugated |
| Immunogen | ADAMTS1 antibody was raised against synthetic 18 amino acid peptide from internal region of human ADAMTS1. Percent identity with other species by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey, Marmoset, Rabbit, Horse, Pig (100%); Bat, Bovine, Panda, Xenopus (94%); Mouse, Dog, Hamster, Elephant, Opossum (89%); Rat, Sheep, Turkey, Chicken (83%). |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Goat Polyclonal Anti-Rab27 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 120 aa to the C-terminus of mouse Rab27a and rab27b produced in E. coli. |
Dopamine Receptor D1 / DRD1 Rabbit Polyclonal (Extracellular Domain) Antibody
| Applications | IHC |
| Reactivities | Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | DRD1 / Dopamine Receptor D1 antibody was raised against synthetic 20 amino acid peptide from 2nd extracellular domain of human DRD1. Percent identity with other species by BLAST analysis: Human, Gorilla, Monkey (100%); Gibbon, Marmoset (95%); Elephant (90%); Dog, Rabbit (85%); Horse (80%). |
Active filters
Reactivities
- Monkey
Conjugates
- Unconjugated
Families
- Druggable Genome
Filter by
Target Symbol
- MAP2K1 (90)
- CTNNB1 (53)
- TP53 (53)
- MAP2K3 (51)
- MAPK1 (24)
- AKT1 (23)
- SNX9 (21)
- UBE2G2 (21)
- BRAF (18)
- HSPD1 (18)
- NONO (18)
- PACSIN3 (18)
- PRKCE (18)
- PSMB7 (18)
- TRIM38 (18)
- TXNDC5 (18)
- ACAT2 (15)
- ATP5F1B (15)
- CLPP (15)
- HDAC6 (15)
- NRBP1 (15)
- PSMA6 (15)
- SENP2 (15)
- SERPINB1 (15)
- SPR (15)
- VBP1 (15)
- CD4 (13)
- AK4 (12)
- BCAR1 (12)
- BUB1B (12)
- EPHX1 (12)
- ERCC4 (12)
- HRAS (12)
- KRT8 (12)
- LMAN1 (12)
- MAPK13 (12)
- NLN (12)
- PGAM2 (12)
- PIK3R5 (12)
- RAB21 (12)
- SERPINA1 (12)
- USP5 (12)
- AK1 (10)
- BECN1 (9)
- CANX (9)
- CDK2 (9)
- CHEK2 (9)
- DPP9 (9)
- ERCC1 (9)
- FMR1 (9)
- GPHN (9)
- KLK8 (9)
- MAPK9 (9)
- MAPRE2 (9)
- PFKP (9)
- PPP5C (9)
- PRKD2 (9)
- PSMA2 (9)
- PSMA4 (9)
- PSMB9 (9)
- RAPGEF1 (9)
- RNF113B (9)
- RPA2 (9)
- SIGLEC9 (9)
- SQSTM1 (9)
- TUBB4A (9)
- XPNPEP3 (9)
- PCNA (8)
- BSG (7)
- CAT (7)
- PFN1 (7)
- SERPINB6 (7)
- STAT1 (7)
- UCHL1 (7)
- UQCRC1 (7)
- ACBD3 (6)
- AK3 (6)
- ALDH1L1 (6)
- ALDH3A2 (6)
- AP2M1 (6)
- APEX1 (6)
- CD22 (6)
- CRYZL1 (6)
- DEF6 (6)
- DLD (6)
- FGG (6)
- FOLH1 (6)
- GLB1 (6)
- GPI (6)
- GTF2F1 (6)
- HDAC1 (6)
- HSP90AB1 (6)
- IVD (6)
- JUN (6)
- KCNJ3 (6)
- L1CAM (6)
- LIMK1 (6)
- MAP2K2 (6)
- MGMT (6)
- NBN (6)
Applications
Antibody Hosts
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (403)
- MAPK signaling pathway (344)
- Prostate cancer (333)
- Colorectal cancer (316)
- Endometrial cancer (316)
- Focal adhesion (303)
- Neurotrophin signaling pathway (295)
- Fc epsilon RI signaling pathway (277)
- Toll-like receptor signaling pathway (271)
- Chronic myeloid leukemia (266)
- Thyroid cancer (265)
- Pancreatic cancer (263)
- Non-small cell lung cancer (259)
- Melanoma (256)
- Glioma (255)
- Metabolic pathways (252)
- T cell receptor signaling pathway (240)
- ErbB signaling pathway (233)
- Progesterone-mediated oocyte maturation (233)
- Insulin signaling pathway (232)
- Bladder cancer (224)
- Chemokine signaling pathway (223)
- GnRH signaling pathway (223)
- Renal cell carcinoma (214)
- Acute myeloid leukemia (210)
- Regulation of actin cytoskeleton (210)
- B cell receptor signaling pathway (203)
- VEGF signaling pathway (198)
- Fc gamma R-mediated phagocytosis (194)
- Melanogenesis (193)
- Natural killer cell mediated cytotoxicity (185)
- Gap junction (183)
- Vascular smooth muscle contraction (173)
- Long-term depression (157)
- Long-term potentiation (157)
- Wnt signaling pathway (146)
- Amyotrophic lateral sclerosis (ALS) (140)
- Oocyte meiosis (138)
- Prion diseases (135)
- Dorso-ventral axis formation (122)
- Apoptosis (121)
- Basal cell carcinoma (113)
- Small cell lung cancer (112)
- Tight junction (112)
- Cell cycle (110)
- Leukocyte transendothelial migration (107)
- Adherens junction (100)
- Huntington's disease (97)
- mTOR signaling pathway (94)
- Pathogenic Escherichia coli infection (92)
- p53 signaling pathway (85)
- Type II diabetes mellitus (80)
- Neuroactive ligand-receptor interaction (76)
- Alzheimer's disease (71)
- Proteasome (70)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (66)
- Jak-STAT signaling pathway (65)
- NOD-like receptor signaling pathway (64)
- Cell adhesion molecules (CAMs) (58)
- Parkinson's disease (56)
- Axon guidance (55)
- Glycolysis / Gluconeogenesis (52)
- Purine metabolism (49)
- Calcium signaling pathway (48)
- Hematopoietic cell lineage (47)
- Nucleotide excision repair (44)
- Adipocytokine signaling pathway (43)
- Endocytosis (40)
- Valine (40)
- leucine and isoleucine degradation (40)
- Antigen processing and presentation (38)
- TGF-beta signaling pathway (36)
- Epithelial cell signaling in Helicobacter pylori infection (35)
- Ubiquitin mediated proteolysis (33)
- Pyruvate metabolism (31)
- Tryptophan metabolism (31)
- Butanoate metabolism (28)
- Fatty acid metabolism (28)
- RIG-I-like receptor signaling pathway (27)
- Type I diabetes mellitus (27)
- Cytokine-cytokine receptor interaction (26)
- Phosphatidylinositol signaling system (26)
- Complement and coagulation cascades (25)
- Lysine degradation (25)
- Primary immunodeficiency (24)
- Lysosome (23)
- Metabolism of xenobiotics by cytochrome P450 (23)
- Base excision repair (22)
- DNA replication (22)
- Mismatch repair (22)
- Oxidative phosphorylation (22)
- Propanoate metabolism (22)
- RNA degradation (20)
- Folate biosynthesis (18)
- Galactose metabolism (18)
- Homologous recombination (17)
- Pentose phosphate pathway (16)
- Pyrimidine metabolism (16)
- Renin-angiotensin system (16)
- Arachidonic acid metabolism (15)
- Synthesis and degradation of ketone bodies (15)
- Terpenoid backbone biosynthesis (15)
- Glycerolipid metabolism (14)
- Alanine (13)
- Arginine and proline metabolism (13)
- Drug metabolism - cytochrome P450 (13)
- Hypertrophic cardiomyopathy (HCM) (13)
- Regulation of autophagy (13)
- aspartate and glutamate metabolism (13)
- Amino sugar and nucleotide sugar metabolism (12)
- Cardiac muscle contraction (12)
- Histidine metabolism (11)
- Tyrosine metabolism (11)
- Fructose and mannose metabolism (10)
- Notch signaling pathway (10)
- One carbon pool by folate (10)
- Retinol metabolism (10)
- Starch and sucrose metabolism (10)
- Systemic lupus erythematosus (10)
- Viral myocarditis (10)
- beta-Alanine metabolism (10)
- Allograft rejection (9)
- Citrate cycle (TCA cycle) (9)
- Dilated cardiomyopathy (9)
- Glycosaminoglycan degradation (9)
- Vibrio cholerae infection (9)
- Autoimmune thyroid disease (8)
- Basal transcription factors (8)
- Glutathione metabolism (8)
- Hedgehog signaling pathway (8)
- PPAR signaling pathway (8)
- Sphingolipid metabolism (8)
- Ascorbate and aldarate metabolism (7)
- ECM-receptor interaction (7)
- Glycerophospholipid metabolism (7)
- Glycine (7)
- Inositol phosphate metabolism (7)
- Limonene and pinene degradation (7)
- Methane metabolism (7)
- serine and threonine metabolism (7)
- Fatty acid elongation in mitochondria (6)
- Glycosphingolipid biosynthesis - ganglio series (6)
- Maturity onset diabetes of the young (6)
- Other glycan degradation (6)
- Pantothenate and CoA biosynthesis (6)
- Androgen and estrogen metabolism (5)
- Asthma (5)
- Graft-versus-host disease (5)
- C21-Steroid hormone metabolism (4)
- Linoleic acid metabolism (4)
- Nicotinate and nicotinamide metabolism (4)
- Non-homologous end-joining (4)
- Phenylalanine metabolism (4)
- Biosynthesis of unsaturated fatty acids (3)
- Caffeine metabolism (3)
- Cytosolic DNA-sensing pathway (3)
- Drug metabolism - other enzymes (3)
- Riboflavin metabolism (3)
- Steroid biosynthesis (3)
- Taste transduction (3)
- Taurine and hypotaurine metabolism (3)
- ABC transporters (2)
- Olfactory transduction (2)
- D-Glutamine and D-glutamate metabolism (1)
- Ether lipid metabolism (1)
- N-Glycan biosynthesis (1)
- Nitrogen metabolism (1)
- Ribosome (1)
- SNARE interactions in vesicular transport (1)
- alpha-Linolenic acid metabolism (1)